What is known about this subject?
John Jacob Magnet first described miliary tuberculosis owing to a millet seed-like appearance on a chest x-ray. It has various clinical manifestations, making timely diagnosis
What are the implications for research, policy, or practice?
Given the high prevalence and mortality in countries like India, it may not be feasible to wait for microbiological evidence of tuberculosis to initiate therapy. Prompt institution of anti-tubercular therapy with corticosteroids with typical clinical and imaging findings can be lifesaving in these situations.
Background
Tuberculosis is endemic to India: more than two million people suffer from the disease and it claims more than one life every minute. 
Case details
A 24-year-old male, with hypothyroidism for the past two years on 50µg of thyroxine, presented to the outpatient department with complaints of weakness of his left upper limb for the past two days and mild facial deviation towards the right, along with severe headache and neck pain for the past day. He also had a history of evening increase of body temperature with loss of appetite for the past two weeks. There was no history of seizure or altered sensorium. On examination he was febrile with a temperature of 38 o C, conscious and oriented, with left upper limb monoplegia (power 0/5), and upper motor neuron type of left facial weakness. Meningeal signs were absent. Other systemic examinations were unremarkable. There was no history of diabetes mellitus or tuberculosis in the past.
His investigations showed Haemoglobin-12.7gm/dl; WBC5600cu.mm; ESR-10mm/1hr; CSF analysis: WBC-1 (lymphocyte); Sugar-50mg/dl (simultaneous RBS-116 mg/dl); Protein-99 mg/dl; CSF adenosine deaminase assay-5.8. The CSF TB PCR was negative; TSH-10.0; chest x-raymiliary mottling ( Figure 1 ); HRCT-bilateral miliary lesions (Figures 2a and 2b ). An MRI of the brain showed a few small enhancing nodular lesions involving bilateral brain parenchyma, possibly tuberculomas within basal cisterna magna (Figures 3a, 3b, and 3c ). Sputum AFB, Mantoux test, HbsAg, AntiHCV, HIV, and VDRL were negative. The patient was started on dexamethasone and antitubercular treatment, pending sputum and CSF culture report. His thyroxine dose was also increased to 100µg. On the second day of treatment, his weakness started resolving and the facial deviation resolved. He was discharged in stable condition. The patient has been under regular followup for the past 16 weeks and is doing well. He has no symptoms and his repeat chest x-ray shows complete resolution of the miliary pattern (Figure 4 ). 
Discussion
Brain tuberculoma is a non-neoplastic mass caused by Mycobacterium tuberculosis. It usually occurs in immunocompromised individuals due to haematogenous or lymphatic spread from primary focus, mainly the lungs. CNS tuberculoma usually presents with ophthalmic symptoms, intracranial hypertension, papilloedema, hemiplegia, hemiparesis, monoplegia, aphasia, cerebellar syndromes, cranial nerve lesions, and epilepsy. 3 Tumor necrosis factor (TNF) alpha has been considered as an important cytokine in the neuropathogenesis of M. tuberculosis. 4 It alters the blood brain barrier permeability and triggers CSF leukocytosis. Tuberculomas are firm, avascular, spherical masses, with size varying between 2cm and 10cm in diameter. They are well circumscribed, and the compressed surrounding brain tissue shows oedema and gliosis. 5 John Jacob Magnet first described miliary tuberculosis as a form of disseminated tuberculosis. It is difficult to diagnose because of its various atypical presentations such as normal chest x-ray, abnormal behaviour with tubercular meningitis, hyponatremia, and skin manifestations. It mainly manifests in immunocompromised individuals. Mortality from this disease is very high despite effective therapy. 6 Although miliary tuberculosis is known to cause hypothyroidism, 10 this was unlikely in our case as the patient was already on treatment for the past two years.
India is a high burden country for tuberculosis. If a patient presents with a clinical picture and a chest x-ray compatible with miliary tuberculosis, it is common practice to start treatment immediately due to the condition's high fatality rate. Our patient has completed the intensive phase of the treatment and is currently doing well on two drugs. His neurological symptoms have resolved completely with a power of 5/5 in his left upper limb. He is afebrile with improved appetite. His follow-up chest x-ray shows complete resolution of the miliary shadow.
Conclusion
Although the combination of CNS tuberculoma and miliary tuberculosis is common in immunocompromised patients, its occurrence in immunocompetent individuals has been reported very infrequently. Our case clearly demonstrates that immunocompetent patients might also present with this rare duo, and prompt imaging and CSF studies followed by rapid institution of steroid and anti-tubercular therapy, even in the absence of microbiological evidence, may not only be lifesaving, but limb saving as well.
